Your browser doesn't support javascript.
loading
Reciprocal regulation of SIRT1 and AMPK by Ginsenoside compound K impedes the conversion from plasma cells to mitigate for podocyte injury in MRL/lpr mice in a B cell-specific manner.
Song, Ziyu; Jin, Meng; Wang, Shenglong; Wu, Yanzuo; Huang, Qi; Xu, Wangda; Fan, Yongsheng; Tian, Fengyuan.
Afiliación
  • Song Z; First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
  • Jin M; First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
  • Wang S; First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
  • Wu Y; First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
  • Huang Q; Department of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
  • Xu W; First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
  • Fan Y; College of Basic Medical Science, Institute of Basic Research in Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
  • Tian F; First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
J Ginseng Res ; 48(2): 190-201, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38465215
ABSTRACT

Background:

Deposition of immune complexes drives podocyte injury acting in the initial phase of lupus nephritis (LN), a process mediated by B cell involvement. Accordingly, targeting B cell subsets represents a potential therapeutic approach for LN. Ginsenoside compound K (CK), a bioavailable component of ginseng, possesses nephritis benefits in lupus-prone mice; however, the underlying mechanisms involving B cell subpopulations remain elusive.

Methods:

Female MRL/lpr mice were administered CK (40 mg/kg) intragastrically for 10 weeks, followed by measurements of anti-dsDNA antibodies, inflammatory chemokines, and metabolite profiles on renal samples. Podocyte function and ultrastructure were detected. Publicly available single-cell RNA sequencing data and flow cytometry analysis were employed to investigate B cell subpopulations. Metabolomics analysis was adopted. SIRT1 and AMPK expression were analyzed by immunoblotting and immunofluorescence assays.

Results:

CK reduced proteinuria and protected podocyte ultrastructure in MRL/lpr mice by suppressing circulating anti-dsDNA antibodies and mitigating systemic inflammation. It activated B cell-specific SIRT1 and AMPK with Rhamnose accumulation, hindering the conversion of renal B cells into plasma cells. This cascade facilitated the resolution of local renal inflammation. CK facilitated the clearance of deposited immune complexes, thus reinstating podocyte morphology and mobility by normalizing the expression of nephrin and SYNPO.

Conclusions:

Our study reveals the synergistic interplay between SIRT1 and AMPK, orchestrating the restoration of renal B cell subsets. This process effectively mitigates immune complex deposition and preserves podocyte function. Accordingly, CK emerges as a promising therapeutic agent, potentially alleviating the hyperactivity of renal B cell subsets during LN.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Ginseng Res Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: J Ginseng Res Año: 2024 Tipo del documento: Article País de afiliación: China